Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2025-12-30 @ 2:16 AM
Study NCT ID:
NCT03029832
Status:
TERMINATED
Last Update Posted:
2019-05-31
First Post:
2017-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Therapy
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-27
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-25
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-18
First Submit QC Date:
None
Study First Post Date:
2017-01-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-04-24
Results First Submit QC Date:
None
Results First Post Date:
2019-05-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-30
Last Update Post Date:
2019-05-31
Last Update Post Date Type:
ACTUAL